Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: Pulmosphere

Aerosolized Antibiotics & Selling Nebulizers

Posted on March 25, 2015 by Harald — No Comments ↓

“The medicine comes for free, just pay us for the inhaler” should be the marketing slogan for this group of therapeutics.  Nebulizers are good business: hard to copy as a delivery system, they are a great opportunity to ‘evergreen’ off-patent antibiotics. The inhalational route to administer antibiotics is clearly attractive.  Continue reading Aerosolized Antibiotics & Selling Nebulizers→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...
Posted in QIDP Antibiotics, The News, The Viewpoint | Tagged AeroVanc, antibiotic blog, Aradigm, Arikayce, aspergillosis, aztreonam, Bayer, bronchiectasis, bronchiolitis, Cardeas, Cayston, ciprofloxacin, cystic fibrosis, DPI, FDA, FEV1, fosfomycin, inhaled antibiotics, Insmed, levofloxacin, Nektar, Novartis, PARI eFlow nebulizer, pentamidine, PodHaler, Pulmosphere, RSV, Sawara, TOBI, tobramycin, vancomycin, Ventolin | Leave a reply

Go back

Your message has been sent

Rating(required)
Warning

Footer Menu

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2026 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d